Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Laronde Attracts $440M in First External Financing to Further Advance Endless™ RNA Platform

Laronde 08.30.2021

Dr. Stephen Hahn, 24th U.S. FDA Commissioner and former Chief Medical Executive at MD Anderson, joins Flagship Pioneering as Chief Medical Officer of its Preemptive Medicine and Health Security Initiative

06.14.2021

Flagship Pioneering Closes $3.4 Billion Capital Pool to Drive Continued Breakthrough Innovations in Human Health and Sustainability

06.14.2021

Flagship Pioneering Unveils Laronde to Advance Endless RNA™ - A New Class of Programmable Medicines Capable of Expressing Therapeutic Proteins Inside the Body

Laronde 05.10.2021

Flagship Pioneering Expands Biotech Footprint to Property in Somerville’s Boynton Yards

Tessera Therapeutics, Cellarity 03.31.2021

Omega Therapeutics to Advance Pipeline and Platform Development with $126 Million in Additional Financing

Omega Therapeutics 03.31.2021

Flagship Pioneering Expands Leadership Team with Appointment of Michael T. Nally as CEO-Partner

Generate Biomedicines 03.31.2021

Sana Announces Upsized Pricing of Initial Public Offering

Sana Biotechnology 02.04.2021

Flagship Pioneering Unveils Inzen Therapeutics

Inzen Therapeutics 01.12.2021

Flagship Pioneering’s Participation in 2021 JP Morgan Healthcare Conference Includes Company Presentations; Founder Dialogue

01.11.2021

Loading